Bio-Techne (TECH) Liabilities from Discontinued Operations (2023 - 2024)
Bio-Techne (TECH) recorded quarterly Liabilities from Discontinued Operations of 689000.0 in Q1 2024, down 56.75% quarter-over-quarter from 1593000.0 in Q4 2023.
Bio-Techne (TECH) Liabilities from Discontinued Operations (2023 - 2024) Analysis & Trends
Bio-Techne's Liabilities from Discontinued Operations history runs 2 years deep, the most recent figure standing at 689000.0 for Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Bio-Techne | 9.04 Bn | 8.83 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 689,000.00 |
| Mar 31, 2024 | 689,000.00 |
| Dec 31, 2023 | 1.59 Mn |
| Dec 31, 2023 | 1.59 Mn |